InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Thornton Michael Milos, Chief Technology Officer. Insider active across 1 companies, notably ENDRA Life Sciences Inc.. Aggregated, 4 reports have been published. Total volume traded: €10k. The latest transaction was disclosed on 26 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€4,89125,000 shares@ €0.19570.078% mcap48.2% of flow
Common Stock
SEC:0001209191-22-032746:0·
Ideal exit: 20 Feb 2023 (T+270)
€5,25225,000 shares@ €0.21010.084% mcap51.8% of flow
Common Stock
SEC:0001209191-22-031319:0·
Ideal exit: 12 Feb 2023 (T+270)
022,815 shares0
Common Stock
SEC:0001209191-21-057234·
022,815 shares0
Common Stock
SEC:0001209191-21-057234:0·
4 of 4 declarations
About Thornton Michael Milos
Michael Milos Thornton is the Chief Technology Officer at ENDRA Life Sciences Inc. He is responsible for the technical direction of the company, overseeing the development of new technologies and innovation. His technical expertise is crucial for the company's success in the life sciences sector, contributing to the improvement of healthcare solutions.
